GENE ONLINE|News &
Opinion
Blog

Funding
Forbion Secures $1.48 Billion For Its Newest Funds, With Plans To Grow Biotechs
2023-04-20
Pfizer-backed Flare Taps Caris To Boost Precision Oncology Pipeline
2023-04-17
In-Home Kidney Disease Management Company, Monogram, Raises $375 Million
2023-01-13
Belharra Therapeutics Exits Stealth With $130 Million And A Genentech Deal
2023-01-05
Zenas Picks Up $118 Million To Advance Phase 3 For Autoimmune Candidate
2022-11-10
Nineteen Grants and Two Contracts Grab $38 Million In Support From the FDA
2022-10-17
Andera Partners Drums Up $443 Million For Its Largest Life Sciences Fund
2022-10-11
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Theravance Allots $250 Million to Repurchase Shares, Removing GSK as a Shareholder
2022-09-20
Big Pharma-Backed Capstan Launches With $165 Million To Combine Cell Therapy And mRNA Technology
2022-09-15
Forge Biologics Raises $90 Million To Expand Gene Therapy CDMO
2022-09-14
Series D Funding Brings Radiopharmaceutical Company RayzeBio to $418 million in Total
2022-09-13
Pretzel Therapeutics Starts Off With $72.5 Million To Modify Mitochondria
2022-09-13
Competing With BMS’s New Psoriasis Drug, Nimbus Gathers $125 Million to Advance Development
2022-09-13
RNA-Focused Orbital Therapeutics Makes its Industry Debut with Beam Partnership
2022-09-08
1 2 3 10
LATEST
Pfizer’s RSV Vaccine Gets FDA Approval for Use in Older Adults
2023-05-31
Brazil’s Evolving ESG Landscape from the Amazon to Atlantic Forest
2023-05-31
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD, PhD
2023-05-26
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
CDC Calls an End to J&J’s COVID-19 Vaccine in the U.S.
2023-05-25
A Close Look at the Evolution of ESG in Biopharma
2023-05-22
Scroll to Top